How big is the Mexico Aesthetic Devices Market?

The Mexico Aesthetic Devices Market size is expected to reach USD 545.47 million in 2024 and grow at a CAGR of 8.33% to reach USD 813.79 million by 2029. Read More

What is the current Mexico Aesthetic Devices Market size?

In 2024, the Mexico Aesthetic Devices Market size is expected to reach USD 545.47 million. Read More

Who are the key players in Mexico Aesthetic Devices Market?

Abbvie (Allergan Inc.), Bausch Health Companies (Solta Medical), Johnson & Johnson Inc., Galderma SA and Hologic Inc. are the major companies operating in the Mexico Aesthetic Devices Market. Read More

What years does this Mexico Aesthetic Devices Market cover, and what was the market size in 2023?

In 2023, the Mexico Aesthetic Devices Market size was estimated at USD 500.03 million. The report covers the Mexico Aesthetic Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Mexico Aesthetic Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Mexico Aesthetic Devices Market Share

Statistics for the 2023 & 2024 Mexico Aesthetic Devices market share, created by Mordor Intelligence™ Industry Reports. Mexico Aesthetic Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Mexico Aesthetic Devices Industry

The Mexican aesthetic devices market is consolidated and consists of a few major players. In terms of market share, a few of the major players are dominating the market, and some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the companies that are currently dominating the market include Abbvie (Allergan Inc.), Cynosure Inc., Johnson & Johnson Inc., Sisram Medical Ltd (Alma Lasers Ltd), Galderma SA, Syneron Inc. (Candela Corporation), Venus Concept Ltd, Hologic Inc., Bausch Health Companies Inc. (Solta Medical Inc.), and Merz Pharma GmbH & Co. KGaA.